At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SERA Sera Prognostics, Inc.
Pre-Mkt 08-27 08:11:22 EDT
2.09
-0.09
-4.13%
High2.18Low2.09Vol7.23K
Open2.18D1 Closing2.18Amplitude4.13%
Mkt Cap82.45MTradable Cap66.51MTotal Shares39.45M
T/O15.50KT/O Rate0.02%Tradable Shares31.82M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Sera Prognostics Says PRIME Trial Shows PreTRM-Guided Care Cuts Preterm Births Before 32 Weeks by over 50%
Reuters  ·  08-25 20:02
Sera Prognostics Says PRIME Trial Shows PreTRM-Guided Care Cuts Preterm Births Before 32 Weeks by over 50%
Undervalued Penny Stocks To Consider In August 2026
Simply Wall St.  ·  08-25 01:05
Undervalued Penny Stocks To Consider In August 2026
Sera Prognostics Announces CFO Transition and Succession Plan
TIPRANKS  ·  08-20
Sera Prognostics Announces CFO Transition and Succession Plan
Sera Prognostics Names Scott Gleason CFO Effective Aug. 31
Reuters  ·  08-20
Sera Prognostics Names Scott Gleason CFO Effective Aug. 31
Sera Prognostics, - Austin Aerts to Transition from CFO to Advisory Role
THOMSON REUTERS  ·  08-20
Sera Prognostics, - Austin Aerts to Transition from CFO to Advisory Role
Vivos Therapeutics Q2 Revenue Rises 35% on Service Growth
Reuters  ·  08-15
Vivos Therapeutics Q2 Revenue Rises 35% on Service Growth
Analyst Reiterates Buy on Sera Prognostics, Citing Expanding Payer Coverage and Large Long‑Term Market Opportunity
TIPRANKS  ·  08-13
Analyst Reiterates Buy on Sera Prognostics, Citing Expanding Payer Coverage and Large Long‑Term Market Opportunity
Sera Prognostics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  08-13
Sera Prognostics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary
Sera Prognostics Q2 Revenue Rises on Expanded Partnerships and Medicaid Coverage
Reuters  ·  08-13
Sera Prognostics Q2 Revenue Rises on Expanded Partnerships and Medicaid Coverage
Sera Prognostics Q2 EPS USD -0.18
THOMSON REUTERS  ·  08-13
Sera Prognostics Q2 EPS USD -0.18
Sera Prognostics Q2 FY26 Net Loss Widens to $9.14 Million; Revenue Rises 76.47% to $30,000
Reuters  ·  08-13
Sera Prognostics Q2 FY26 Net Loss Widens to $9.14 Million; Revenue Rises 76.47% to $30,000
Sera Prognostics Q2 EPS $(0.18) Misses $(0.15) Estimate, Sales $30.000K Miss $57.500K Estimate
Benzinga Earnings  ·  08-13
Sera Prognostics Q2 EPS $(0.18) Misses $(0.15) Estimate, Sales $30.000K Miss $57.500K Estimate
Press Release: SERA Prognostics Reports Second Quarter 2026 Financial Results
Dow Jones  ·  08-13
Press Release: SERA Prognostics Reports Second Quarter 2026 Financial Results
Sera Prognostics, Inc. Expected to Post a Loss of 15 Cents a Share - Earnings Preview
Reuters  ·  08-11
Sera Prognostics, Inc. Expected to Post a Loss of 15 Cents a Share - Earnings Preview
Sera Prognostics Schedules Conference Call, Webcast for Quarterly Results Update
Reuters  ·  07-30
Sera Prognostics Schedules Conference Call, Webcast for Quarterly Results Update
Sera Prognostics management to meet virtually with Craig-Hallum
TIPRANKS  ·  07-15
Sera Prognostics management to meet virtually with Craig-Hallum
Sera Prognostics’ PreTRM Test shows efficacy guiding first-time pregnancy care
TIPRANKS  ·  07-10
Sera Prognostics’ PreTRM Test shows efficacy guiding first-time pregnancy care
Sera Prognostics Announces New PRIME Subgroup Analysis Publication on Pretrm Test-guided Care
Reuters  ·  07-10
Sera Prognostics Announces New PRIME Subgroup Analysis Publication on Pretrm Test-guided Care
Sera Prognostics Director Mark Christopher Capone Files Initial Beneficial Ownership Statement
Reuters  ·  07-02
Sera Prognostics Director Mark Christopher Capone Files Initial Beneficial Ownership Statement
Sera Prognostics Adds Veteran Executive to Board
TIPRANKS  ·  07-01
Sera Prognostics Adds Veteran Executive to Board

Introduction

Company Name.
Sera Prognostics, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--